
Argonaute - Wikipedia
The Argonaute (AGO) gene family encodes six characteristic domains: N- terminal (N), Linker-1 (L1), PAZ, Linker-2 (L2), Mid, and a C-terminal PIWI domain. [8]
Argonaute 2蛋白(AGO2)是什么? - 知乎专栏
Jul 30, 2024 · Argonaute 2蛋白 (AGO2),亦称 真核翻译起始因子2C2 ( eukaryotic translation initiation factor 2C subunit 2,EIF2C2) 。含有N末端( amino-terminal) 、PAZ、MID 和PIWI 四 …
AGO2 Gene - GeneCards | AGO2 Protein | AGO2 Antibody
Dec 24, 2024 · AGO2 (Argonaute RISC Catalytic Component 2) is a Protein Coding gene. Diseases associated with AGO2 include Lessel-Kreienkamp Syndrome and Non-Specific …
ago2蛋白有什么用? - 华美生物
Oct 16, 2023 · AGO2(Argonaute 2)蛋白是RNA干扰(RNAi)和微小RNA(miRNA)通路中的一种关键因子,具有重要的生物学功能。 具体来说,AGO2蛋白可与小RNA(如siRNA …
Germline AGO2 mutations impair RNA interference and human
Nov 16, 2020 · We identify 13 heterozygous mutations in AGO2 in 21 patients affected by disturbances in neurological development. Each of the identified single amino acid mutations …
RNA干扰(二)——船蛸 - 知乎 - 知乎专栏
Ago2也是四种Ago蛋白中表达量最高的一种,诸多实验证明,Ago2就是Slicer酶,活性依赖于二价金属阳离子。 所有四种人类Ago的效应复合物都会引起翻译抑制和mRNA降解。
Structural Dynamics of Human Argonaute2 and Its Interaction with …
The human Argonaute2 protein (Ago2) is a key player in RNA interference pathway and small RNA recognition by Ago2 is the crucial step in siRNA mediated gene silencing mechanism. …
30年的谜题终获解,两篇Science,揭示miRNA靶向降解机制
Nov 19, 2020 · Argonaute (AGO) 蛋白是 RNA 介导的转录后基因调控的关键蛋白,为 miRNA 提供锚位点,形成 RNA 诱导沉默复合体 RISC 达到降解靶基因或者抑制翻译的目的。 自 1993 年 …
超有特色的AGO2抗体 - 知乎 - 知乎专栏
Argonaute2蛋白 (AGO2)通过参与构成 RNA诱导的沉默复合体,其自身催化及自身过表达功能,在人类肿瘤的发生发展中扮演了重要角色,逐渐成为研究焦点。 Ago2表达水平变化或功能失调 …
AGO2 and its partners: a silencing complex, a chromatin ... - PubMed
AGO2 is the only member with catalytic activity in Argonaute family and contains four functional core domains, which are N domain, PAZ domain, MID domain, and PIWI domain from N …
AGO2 localizes to cytokinetic protrusions in a p38-dependent
Jun 11, 2021 · Argonaute 2 (AGO2) is an indispensable component of the RNA-induced silencing complex, operating at the translational or posttranscriptional level. It is compartmentalized into …
AGO2 argonaute RISC catalytic component 2 [ (human)]
Feb 20, 2025 · AGO2 Mediates MYC mRNA Stability in Hepatocellular Carcinoma. Human Argonaute2 and Argonaute3 are catalytically activated by different lengths of guide RNA. …
The structural basis for RNA slicing by human Argonaute2 - Cell …
Mohamed et al. report the cryoelectron microscopy structure of human AGO2 with fully paired guide RNA. Their analysis reveals the structural basis for the slicing activity that drives RNAi, …
The RNA Interference Effector Protein Argonaute 2 Functions as a ...
Aug 15, 2023 · Argonaute 2 (Ago2) is a key component of the RNA interference (RNAi) pathway, a gene-regulatory system that is present in most eukaryotes. Ago2 uses microRNAs (miRNAs) …
Science | 量化microRNA-AGO靶向效率的 - 知乎 - 知乎专栏
近日,Whitehead研究所 David P. Bartel 研究组在 Science 发表文章 The biochemical basis of microRNA targeting efficacy,对RNA bind-n-seq(RBNS)测序进行优化,用于 测量miRNA …
Argonaute 2蛋白(AGO2)是什么?_基因_功能_家族 - 搜狐
Jul 31, 2024 · Argonaute 2蛋白(AGO2),亦称真核翻译起始因子2C2 ( eukaryotic translation initiation factor 2C subunit 2,EIF2C2) 。 含有N末端( amino-terminal) 、PAZ、MID 和PIWI 四 …
AGO2 and its partners: a silencing complex, a chromatin modulator…
Mar 13, 2020 · In traditional view, AGO2 serves as the catalytic engine of the RNA induced silencing complex and plays an important role in small RNAs guided post transcriptional gene …
The RNA Interference Effector Protein Argonaute 2 Functions as a ...
Argonaute 2 (Ago2) is a key component of the RNA interference (RNAi) pathway, a gene-regulatory system that is present in most eukaryotes. Ago2 uses microRNAs (miRNAs) and …
Argonaute 2蛋白是什么? - 百家号
Jul 31, 2024 · Argonaute 2蛋白(AGO2),亦称真核翻译起始因子2C2 ( eukaryotic translation initiation factor 2C subunit 2,EIF2C2) 。 含有N末端( amino-terminal) 、PAZ、MID 和PIWI 四 …
Germline AGO2 mutations impair RNA interference and human …
We identify 13 heterozygous mutations in AGO2 in 21 patients affected by disturbances in neurological development. Each of the identified single amino acid mutations result in impaired …